Karyopharm Therapeutics
KPTI
#8721
Rank
HK$0.79 B
Marketcap
HK$6.34
Share price
-2.78%
Change (1 day)
11.19%
Change (1 year)

Market capitalization of Karyopharm Therapeutics (KPTI)

Market cap: HK$0.79 Billion

As of November 2024 Karyopharm Therapeutics has a market cap of HK$0.79 Billion. This makes Karyopharm Therapeutics the world's 8721th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Karyopharm Therapeutics from 2013 to 2024

End of year Market Cap

Year Marketcap Change
2024HK$0.79 B2.63%
2023HK$0.77 B-74.27%
2022HK$3.00 B-20.6%
2021HK$3.78 B-57.11%
2020HK$8.83 B-9.5%
2019HK$9.75 B118.66%
2018HK$4.46 B26.13%
2017HK$3.53 B17.71%
2016HK$3.00 B-18.38%
2015HK$3.68 B-61.2%
2014HK$9.49 B80.53%
2013HK$5.25 B

End of Day market cap according to different sources

On Nov 15th, 2024 the market cap of Karyopharm Therapeutics was reported to be:

HK$0.79 Billion
by Nasdaq info icon info icon
HK$0.79 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
HK$1.896 T 238,737.57%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$887.69 B 111,681.49%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$1.564 T 196,969.89%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$76.59 B 9,544.69%๐Ÿ‡บ๐Ÿ‡ธ USA